Transfer of insulin-like growth factors I and II from plasma to lymph in young goats

Insulin-like growth factors in plasma and afferent mammary lymph of lactating cows deprived of feed or treated with bovine somatotropin

The galactopoietic actions of bovine somatotropin are both direct and indirect. Indirect actions are apparently mediated by the insulin-like growth factor (IGF) system. The objective of this study was to compare systemic (plasma) versus local (lymph) concentrations of IGF. Afferent mammary lymph most nearly represents the extracellular fluid that is bathing mammary tissue. Catheters were surgically implanted in the jugular vein and the superficial afferent mammary lymph vessels of four lactating cows. A crossover design was utilized to evaluate the effects of bovine somatotropin (bST). After 2 d of basal sampling, either bST (40 mg/d) or excipient was administered daily for 5 d. After the conclusion of the bST study, a second study was conducted in which cows were deprived of feed for 36 h. Blood and lymph were simultaneously sampled at least every 6 h throughout both studies. Milk yield was increased by bST, and concentrations of IGF-I were increased in plasma and lymph. The relationship between plasma and lymph concentrations for IGF-II, bST, insulin, glucose, urea nitrogen, and nonesterified fatty acids were similar during bST treatment. Milk yield was reduced 76% by 36 h of feed deprivation. Feed deprivation also caused a reduction of IGF-I in plasma, but concentrations of IGF-I in lymph were not altered. In contrast, changes in IGF-II, bST, insulin, glucose, urea nitrogen, and nonesterified fatty acids that were caused by feed deprivation followed similar patterns in plasma and lymph. Clearly, if IGF-I mediates the mammary actions of bST, then concentrations of IGF-I in plasma correlate with milk yield responses as well as, if not better than, concentrations in lymph.

Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model

Development of the mammary gland during puberty, pregnancy, and lactation is controlled by steroid and peptide hormones and growth factors. To determine the role of the insulin-like growth factors (IGFs) in this process we developed a transgenic model using the whey acidic protein (WAP) gene to direct expression of rat IGF-I and human IGF binding protein-3 (IGFBP-3) to mammary tissue during late pregnancy and throughout lactation. High levels of expression of transgenic IGF-I and IGFBP-3 were seen in lobular-alveolar cells by in situ hybridization. There was no obvious effect on mammary development during pregnancy and lactation; indeed, mothers were capable of nursing their pups normally and the only structural difference seen in the mammary glands at peak lactation was an overall smaller size of the alveoli. We also evaluated the role of IGF-I and IGFBP-3 in the remodeling of mammary tissue during involution. Compared with control animals, the process of involution was modified in both transgenic lines. The degree of apoptotic cells was lower in the WAP-IGF-I and WAP-BP-3 expressing mice. In addition, there was a more quiescent pattern of involution with residual lobular secretary ability and a muted host inflammatory reaction with fewer lumenal microcalcifications. These results demonstrate that IGF-I and IGFBP-3 may modulate the involutionary process of the lactating mammary gland.

Insulin-like growth factor binding proteins of equine serum

Ligand blotting analysis of serum from the horse using radiolabelled IGF-I revealed a protein at 96 kDa which was not present in serum from goat, cow, sheep, deer or donkey. These latter species all displayed five labelled bands in the range 24 to 41 kDa. Conversely, these were only weakly labelled in serum from the horse. Size exclusion chromatography of horse serum pre-incubated with radiolabelled IGF-I revealed reduced binding in the 130-kDa peak compared with goat plasma, and ligand blotting analysis indicated the 96-kDa protein was present in this peak. The 96-kDa protein from horse serum binds IGF-I and IGF-II specifically and appears to be unique to this species. The nature of this protein is at present unknown.